Early Phase I data shows promise for mRNA cancer immunotherapy in advanced solid cancers

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers.

Eli Lilly will ‘build new way of doing science’ in UK amid £297m pledge to government – Pharmaceutical Technology

Ramesh Durvasula leading the opening keynote at the TechBio UK 2024 conference in London. Credit: Jenna Philpott/GlobalData. An Eli Lilly executive has said the company

October 16, 2024

Make the Diagnosis: A Martial Arts Misstep: What’s the Damage?

Presentation An 11-year-old boy presented to the emergency room due to an injury that occurred earlier that day. He had been in a martial arts

April 12, 2024

New radionuclide-based agent offers hope for treating a variety of cancers

A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake, sustained tumor retention, and high contrast in preclinical models, making it

June 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.